| Basics |
Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$462.11B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.68 | 0.64%
|
| Avg Daily Range (30 D): |
$1.29 | 0.71%
|
| Avg Daily Range (90 D): |
$1.13 | 0.66%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
7.97M |
| Avg Daily Volume (30 D): |
6.24M |
| Avg Daily Volume (90 D): |
6.15M |
| Trade Size |
| Avg Trade Size (Sh.): |
140 |
| Avg Trade Size (Sh.) (30 D): |
46 |
| Avg Trade Size (Sh.) (90 D): |
53 |
| Institutional Trades |
| Total Inst.Trades: |
158,656 |
| Avg Inst. Trade: |
$8.19M |
| Avg Inst. Trade (30 D): |
$26.08M |
| Avg Inst. Trade (90 D): |
$25.86M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
28 |
| Market Closing Trades |
| Avg Closing Trade: |
$118.3M |
| Avg Closing Trade (30 D): |
$306.73M |
| Avg Closing Trade (90 D): |
$272.57M |
| Avg Closing Volume: |
924.21K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$9.41
|
$2.3
|
$4.57
|
|
Diluted EPS
|
$9.35
|
$2.29
|
$4.54
|
|
Revenue
|
$ 90.63B
|
$ 23.74B
|
$ 21.89B
|
|
Gross Profit
|
$ 61.55B
|
$ 16.12B
|
$ 14.54B
|
|
Net Income / Loss
|
$ 22.66B
|
$ 5.54B
|
$ 11B
|
|
Operating Income / Loss
|
$ 27.35B
|
$ 6.49B
|
$ 13.63B
|
|
Cost of Revenue
|
$ 29.08B
|
$ 7.63B
|
$ 7.36B
|
|
Net Cash Flow
|
$ -6301M
|
$ -19897M
|
$ 14.37B
|
|
PE Ratio
|
20.64
|
|
|
|
|
|
